Y. Naka et al., COMPLEMENT ACTIVATION AS A CAUSE FOR PRIMARY GRAFT FAILURE IN AN ISOGENEIC RAT MODEL OF HYPOTHERMIC LUNG PRESERVATION AND TRANSPLANTATION, Transplantation, 64(9), 1997, pp. 1248-1255
Although agents that inhibit complement activation may be beneficial i
n discordant xenotransplantation, it is not known whether local comple
ment activation occurs and is deleterious after isogeneic lung transpl
antation, Lungs were harvested from Lewis rats subjected to 4 degrees
C 6-hr preservation followed by transplantation into strain-, gender-,
and weight-matched recipients, Transplanted lungs demonstrated increa
sed immunostaining for C5b-9 compared with nontransplanted controls, c
onfirming local complement activation in this isograft model, To inves
tigate the physiologic relevance of complement activation in the trans
planted lung, the native pulmonary artery was ligated after transplant
ation, and pulmonary vascular resistance (mmHg/ml/min), arterial oxyge
nation (mmHg), graft neutrophil infiltration (myeloperoxidase activity
, Delta Abs 460 nm/min), and recipient survival were measured at 30 mi
n, Animals received either saline (control; n=22) or soluble complemen
t receptor type-1 (sCR1, 15 mg/kg; n=19) 2 min before reperfusion, Ani
mals treated with sCR1 showed a marked reduction in serum complement h
emolytic activity (CH50; 90% lower than that of control animals, P<0.0
01), Compared with controls, sCR1-treated animals showed reduced pulmo
nary vascular resistance (2.9+/-1.1 vs, 8.5+/-1.5 mmHg/ml/min, P<0.05)
, improved arterial oxygenation (194+/-34 vs, 91+/-17 mmHg, P<0.05), d
ecreased neutrophil infiltration (35% decrease, P<0.005), and improved
recipient survival (74% vs, 23%, P<0.005), In parallel with the reduc
tion in complement hemolytic activity in sCR1-treated animals, immunoh
istology of the transplanted lung revealed decreased C5b-9 deposition
compared with controls, Taken together, these data indicate that compl
ement activation occurs after lung preservation and transplantation in
an isograft model, and that inhibiting complement activation improves
outcome after transplantation.